Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers CofiledCriticalBristol Myers Co
Priority to ES472729ApriorityCriticalpatent/ES472729A1/es
Publication of ES472729A1publicationCriticalpatent/ES472729A1/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Un procedimiento para la preparación de unidades de dosificación configuradas de una composición antibacteriana, para la administración oral, constituida por 0,25 a 20 partes aproximadamente de ácido fosfanílico o una sal farmacéuticamente aceptable de la misma; cuyo procedimento comprende combinar profundamente el ácido fosfanílico, la trimetroprima y los ingredientes adicionales necesarios en un equipo mezclador adecuado; granular la combinación obtenida y, posteriormente, tamizarla y comprimirla.
ES472729A1978-08-211978-08-21Un procedimiento para la preparacion de unidades de dosifi- cacion configuradas de una composicion antibacteriana
ExpiredES472729A1
(es)
Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine